Pages

• Diafarm
• Home
• About Faes Farma
  • RSC
  • Faes Farma in figures
  • History
  • Who we are
  • Certificates
  • Reporting of concerns (Whistleblowing)
  • Sustainability (ESG)
    • Statement of Non-financial information 2021
  • R&D+i
  • Faes Farma Websites
• Lines of Business
  • Active Pharmaceutical Ingredients – APIs
  • Portugal
    • In-Licensing
  • Spain
    • In-Licensing
    • Out-Licensing
  • Diafarm
  • Animal Nutrition & Health
    • FARM Faes
      • INGASO FARM
      • INITIAL TECHNICAL FOODS
      • TECNOVIT
    • CIDOSA
    • CAPSELOS
  • International
    • Finished products
    • Opportunities for cooperation
    • International Presence
  • Global Out-Licensing
    • Bilastine
    • Other products
• Products
  • Portugal
  • International Vademecum
• Investors & shareholders
  • General information
    • Dividends
    • Stock Performance
    • Information sent to the CNMV
      • Material Information (before 02/08/2020)
      • Other Relevant Information
      • Inside Information
    • Share Information
  • Corporate Governance
    • Major holdings and own shares
  • Financial Information
    • Analyst reports
    • Annual report
    • Quarterly results
  • Investor’s corner
    • Investors and shareholders contact
    • Investors Site
    • Agenda
• Pharmacovigilance
  • For healthcare professionals
  • For patients
• Press Room
  • Contact
  • Image gallery
• Código de Buenas Prácticas
• Sitemap
• Privacy and cookies policy
• Policy on the privacy of personal data
• Legal Warning
• Pharmacovigilance / Surveillance
  • Surveillance of Medical Devices, Cosmetics, Food, Food Supplements and other products
    • For healthcare professionals
    • For patients
  • Pharmacovigilance
    • For healthcare professionals
    • For patients